Genomic Deletions in Colorectal Cancer Families
Author Information
Author(s): Gille J J P, Hogervorst F B L, Pals G, Wijnen JTh, van Schooten R J, Dommering C J, Meijer G A, Craanen M E, Nederlof P M, de Jong D, McElgunn C J, Schouten J P, Menko F H
Primary Institution: VU University Medical Center
Hypothesis
The study aims to assess the value of the MLPA test for the detection of genomic MSH2- or MLH1-deletions.
Conclusion
The MLPA technique is an efficient method for detecting genomic deletions in MSH2 and MLH1, which are significant causes of hereditary non-polyposis colorectal cancer.
Supporting Evidence
- Thirty-eight germline mutations were detected in 37 (29.4%) of the families studied.
- Among families with MSI-high tumours, 65.7% harboured germline gene defects.
- Genomic deletions accounted for 54.8% of the pathogenic mutations identified.
Takeaway
Scientists found a new way to quickly check for missing pieces in important cancer genes in families with colorectal cancer, helping to find problems that other tests might miss.
Methodology
The study used multiplex ligation-dependent probe amplification (MLPA) to analyze genomic deletions in MSH2 and MLH1 in colorectal cancer families.
Limitations
The study's findings may not be generalizable to all populations, as it focused on Dutch colorectal cancer families.
Participant Demographics
Participants were colorectal cancer families, including those meeting Amsterdam criteria and others with suspected hereditary non-polyposis colorectal cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website